全球多重诊断市场

到 2030 年，全球多重诊断市场规模将达到 286 亿美元

全球多重诊断市场预计 2024 年为 136 亿美元，到 2030 年将达到 286 亿美元，2024 年至 2030 年的复合年增长率为 13.2%。设备及配件是报告中分析的细分市场之一，预计复合年增长率为 11.0%，到分析期结束时将达到 154 亿美元。在分析期内，套件和试剂部分的复合年增长率预计为 16.1%。

美国市场估计为37亿美元；预计中国年复合成长率为 17.3%

预计 2024 年美国多重诊断市场价值将达到 37 亿美元。作为世界第二大经济体的中国，预计到 2030 年市场规模将达到 60 亿美元，在 2024-2030 年分析期内的复合年增长率为 17.3%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 9.8% 和 11.6%。在欧洲，德国的复合年增长率预计为 10.4%。

全球多重诊断市场－主要趋势与驱动因素摘要

为什么多重诊断在临床和 POC 检测中越来越受欢迎

多重诊断是指能够从单一生物样本同时检测多种分析物（例如蛋白质、核酸和病原体）的分析平台。这种方法显着提高了诊断效率，缩短了周转时间，并节省了样本量，使其在传染病检查、肿瘤学、自体免疫疾病筛检和药物基因组学领域中越来越有吸引力。随着对更快、更全面和更少侵入性测试的需求不断增加，多重技术在集中式实验室和分散式护理点 (POC) 环境中变得越来越重要。

与传统的单一分析物测试相比，多重分析可以提高诊断率并支持同时探讨多种疾病原因的综合测试方法。例如，呼吸道多重检测面板可以同时检测流感、SARS-CoV-2、RSV 和其他病原体，从而实现即时治疗决策。这在流行病期间和免疫力缺乏的患者群体中尤其有用。随着医疗保健系统向精准医疗和基于价值的护理模式发展，多重诊断提供了提供更丰富数据、降低每次测试成本和加快临床决策週期的手段。

技术进步如何提升多重化能力和临床效用？

微流体、生物感测器小型化、实验室晶片平台和数位检测技术的创新正在彻底改变多路復用诊断的性能和可访问性。 Luminex以微珠为基础的系统、PCR 微阵列、次世代定序(NGS) 和电化学生物感测器可实现具有高灵敏度、特异性和高通量的多重检测。这些平台现在可以整合到桌上型分析仪、POC 墨盒或穿戴式装置中，从而扩大其在传统实验室环境之外的用途。

多重技术（例如条码探针面板和多路復用 ELISA 格式）正在扩大可在单次测试中检测到的目标数量。基于 CRISPR 的诊断和等温扩增方法正在实现低成本、可现场部署的多路復用平台。同时，人工智慧演算法和云端基础的分析正在整合到诊断工作流程中，以解释复杂的多重数据并支援可操作的见解。自动化、小型化和智慧连接正在推动向可携式、用户友好的多重测试系统的转变，适用于诊所、紧急环境甚至家庭诊断。

哪些疾病领域和医疗保健模式正在推动多重诊断的需求？

感染疾病仍然是一个主要的应用领域，多重面板被广泛用于识别与呼吸道感染疾病、性行为感染感染 (STI)、胃肠道疾病和败血症相关的病原体。肿瘤学是一个新兴的焦点，多重检测用于突变分析、伴随诊断和液态切片应用，这些应用需要同时检测多种基因变异和/或生物标记。自体免疫和过敏诊断也受益于测量多种抗体和细胞激素谱的多重免疫测量。

由于需要整合工作流程和加快诊断速度，医院、临床实验室、参考文献实验室和紧急护理中心是多重诊断的主要机构使用者。此外，透过快速门诊、远端医疗网路和行动医疗单位进行的分散式检查的兴起，正在推动对只需最低限度的技术培训即可操作的紧凑型多路復用系统的需求。在基础设施受限的情况下，中低收入国家正在探索综合多重平台作为扩大诊断覆盖率的一种经济有效的方式。

什么将推动多重诊断市场的长期成长和创新？

由于疾病日益复杂以及公共卫生监测的需要，全球对快速、高通量和全面的诊断解决方案的需求推动了多重诊断市场的成长。疫情防治、抗菌药物管理和个人化肿瘤学正在共同加速多重检测的采用。对综合测试面板的监管支援和先进诊断工具的保险报销也增加了市场的可行性。

开发人员正在投资扩展面板内容、提高检体处理的自动化程度以及开发模组化平台以适应机构工作流程。诊断公司、生物技术公司和医疗保健提供者之间的策略伙伴关係正在推动综合诊断和治疗平台的联合发展。此外，即时疾病监测、远端携带式多路復用设备以及与数位健康的整合正在扩大这些技术的临床效用。

随着医疗保健越来越以数据主导并以患者为中心，多重诊断对于实现早期检测、个人化治疗和全系统效率至关重要，从而决定全球医疗保健生态系统诊断的未来。

部分

产品类型（仪器及配件、套件及试剂）；应用（感染疾病、肿瘤学、自体免疫疾病、心臟病学、过敏、其他应用）；最终用户（医院、诊断中心、其他最终用户）

受访公司范例（43家值得关注的公司）

• Abbott Laboratories
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• BioFire Diagnostics
• BioMerieux SA
• Bio-Rad Laboratories, Inc.
• Co-Diagnostics, Inc.
• DiaSorin SpA
• Exact Sciences Corporation
• Hologic, Inc.
• Illumina, Inc.
• Luminex Corporation
• NanoString Technologies, Inc.
• QIAGEN NV
• QuidelOrtho Corporation
• Randox Laboratories
• Roche Diagnostics
• Seegene Inc.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口（成品和OEM）预测公司竞争地位的变化。这种复杂且多方面的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、降低盈利、重组供应链等微观和宏观市场动态。

全球产业分析师密切关注世界领先的首席经济学家（14,949）、智库（62）和贸易及产业协会（171）的专家意见，以评估生态系统的影响并应对新的市场现实。各主要国家的专家和经济学家都在关注关税及其对国家的影响。

全球产业分析师预计，这种动盪将在未来几个月内平息，新的世界秩序将更加明确地建立。全球产业分析师正在即时追踪这些发展。

2025年4月：谈判阶段

我们四月份的发布将涵盖关税对全球市场整体的影响，并为各地区的市场调整提供指导。我们的预测是基于历史数据和不断发展的市场影响因素。

2025年7月：最终关税调整

在各国宣布最终重置后，客户将于 7 月收到免费更新。最终更新包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业和领域专家的最具影响力的首席经济学家，他们共用了全球经济状况这一前所未有的模式转移的影响。我们的 16,491 多份报告中的大多数都遵循这个基于两阶段里程碑的发布计划。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Multiplexed Diagnostics Market to Reach US$28.6 Billion by 2030

The global market for Multiplexed Diagnostics estimated at US$13.6 Billion in the year 2024, is expected to reach US$28.6 Billion by 2030, growing at a CAGR of 13.2% over the analysis period 2024-2030. Instruments & Accessories, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$15.4 Billion by the end of the analysis period. Growth in the Kits & Reagents segment is estimated at 16.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.7 Billion While China is Forecast to Grow at 17.3% CAGR

The Multiplexed Diagnostics market in the U.S. is estimated at US$3.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.0 Billion by the year 2030 trailing a CAGR of 17.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.8% and 11.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.4% CAGR.

Global Multiplexed Diagnostics Market - Key Trends & Drivers Summarized

Why Is Multiplexed Diagnostics Gaining Prominence in Clinical Laboratories and Point-of-Care Testing?

Multiplexed diagnostics refers to analytical platforms capable of simultaneously detecting multiple analytes-such as proteins, nucleic acids, or pathogens-from a single biological sample. This approach significantly improves diagnostic efficiency, reduces turnaround time, and conserves sample volume, making it increasingly attractive for use in infectious disease testing, oncology, autoimmune disorder screening, and pharmacogenomics. With rising demand for faster, more comprehensive, and minimally invasive testing, multiplexing technologies are becoming central to both centralized laboratories and decentralized point-of-care (POC) settings.

Compared to traditional single-analyte tests, multiplex assays enhance diagnostic yield and support syndromic testing approaches where multiple causes of a condition are investigated in parallel. For example, respiratory multiplex panels can concurrently detect influenza, SARS-CoV-2, RSV, and other pathogens-guiding treatment decisions in real time. This is particularly valuable during epidemics or in immunocompromised patient populations. As healthcare systems transition toward precision medicine and value-based care models, multiplexed diagnostics provide a means to deliver richer data at lower per-test costs and faster clinical decision cycles.

How Are Technological Advancements Enhancing Multiplexing Capabilities and Clinical Utility?

Innovations in microfluidics, biosensor miniaturization, lab-on-chip platforms, and digital detection technologies are revolutionizing the performance and accessibility of multiplexed diagnostics. Luminex bead-based systems, PCR microarrays, next-generation sequencing (NGS), and electrochemical biosensors are enabling multiplex assays with high sensitivity, specificity, and throughput. These platforms can now be integrated into benchtop analyzers, POC cartridges, or wearable devices-extending their use beyond traditional laboratory environments.

Digital multiplexing techniques, such as barcoded probe panels and multiplexed ELISA formats, are expanding the number of targets that can be detected in a single run. CRISPR-based diagnostics and isothermal amplification methods are enabling low-cost, field-deployable multiplex platforms. Simultaneously, AI algorithms and cloud-based analytics are being integrated into diagnostic workflows to interpret complex multiplex data and support actionable insights. Automation, miniaturization, and smart connectivity are driving a shift toward portable, user-friendly multiplex testing systems suitable for clinics, emergency settings, and even home diagnostics.

Which Disease Areas and Healthcare Models Are Driving Demand for Multiplexed Diagnostics?

Infectious diseases remain the dominant application area, with multiplex panels used extensively for respiratory infections, sexually transmitted infections (STIs), gastrointestinal diseases, and sepsis-related pathogen identification. Oncology is an emerging focus, where multiplexed assays are used for mutation profiling, companion diagnostics, and liquid biopsy applications that require the simultaneous detection of multiple gene alterations or biomarkers. Autoimmune and allergy diagnostics are also benefiting from multiplexed immunoassays that measure multiple antibody or cytokine profiles.

Hospitals, clinical laboratories, reference labs, and urgent care centers are the key institutional users of multiplex diagnostics, driven by the need for workflow consolidation and faster diagnostic turnaround. Additionally, the rise of decentralized testing through retail health clinics, telemedicine networks, and mobile health units is creating demand for compact multiplex systems that can be operated with minimal technical training. Low- and middle-income countries are exploring syndromic multiplex platforms as a cost-effective way to expand diagnostic reach amid infrastructure constraints.

What Is Driving Long-Term Growth and Innovation in the Multiplexed Diagnostics Market?

The growth in the multiplexed diagnostics market is driven by the global demand for rapid, high-throughput, and comprehensive diagnostic solutions amid increasing disease complexity and public health surveillance needs. Outbreak preparedness, antimicrobial stewardship, and oncology personalization are aligning to accelerate the adoption of multiplex assays. Regulatory support for syndromic testing panels and reimbursement coverage for advanced diagnostic tools are also reinforcing market viability.

Manufacturers are investing in expanding panel content, improving sample processing automation, and developing modular platforms that can be tailored to institutional workflows. Strategic partnerships between diagnostic firms, biotech companies, and healthcare providers are driving co-development of integrated diagnostic-treatment platforms. Additionally, real-time disease monitoring, portable multiplex devices for remote settings, and digital health integration are extending the clinical utility of these technologies.

As healthcare delivery becomes increasingly data-driven and patient-centric, multiplexed diagnostics will serve as an essential enabler of early detection, personalized therapy, and system-wide efficiency-defining the future of diagnostics across global healthcare ecosystems.

SCOPE OF STUDY:

The report analyzes the Multiplexed Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Instruments & Accessories, Kits & Reagents); Application (Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies, Other Applications); End-User (Hospitals, Diagnostic Centers, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• Abbott Laboratories
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• BioFire Diagnostics
• BioMerieux SA
• Bio-Rad Laboratories, Inc.
• Co-Diagnostics, Inc.
• DiaSorin S.p.A.
• Exact Sciences Corporation
• Hologic, Inc.
• Illumina, Inc.
• Luminex Corporation
• NanoString Technologies, Inc.
• QIAGEN N.V.
• QuidelOrtho Corporation
• Randox Laboratories
• Roche Diagnostics
• Seegene Inc.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Multiplexed Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for High-Throughput Testing in Infectious Disease Panels Drives Adoption of Multiplexed Diagnostics
  • Expansion of Syndromic Testing Platforms Throws the Spotlight on Multi-Analyte Diagnostic Capabilities
  • Growth in Point-of-Care and Near-Patient Testing Fuels Use of Compact Multiplex Systems
  • Advancements in Microfluidics and Lab-on-Chip Technologies Propel Miniaturization and Portability
  • Increased Integration of AI and Data Analytics Enhances Interpretation of Complex Diagnostic Profiles
  • Surge in Oncology Biomarker Panels Spurs Innovation in Multi-Gene Expression Assays
  • Widespread Adoption in Respiratory Virus Detection Strengthens Market for Flu-COVID-RSV Panels
  • Regulatory Support for Panel-Based Diagnostics Accelerates Approvals in Infectious Disease Management
  • Focus on Personalized Medicine Drives Development of Targeted Multiplex Companion Diagnostics
  • Use of Multiplex PCR and Next-Generation Sequencing Expands Platform Versatility Across Indications
  • Demand for Cost-Effective Testing in Resource-Limited Settings Spurs Adoption of Multiplex Formats
  • Growth in Antibiotic Stewardship Programs Strengthens Relevance of Rapid Pathogen Identification Panels
  • Increased Use in Transplant, Sepsis, and Autoimmune Disease Diagnostics Broadens Clinical Utility
  • Collaborations Between Diagnostic Firms and Pharma Companies Enhance Drug-Response Testing Capabilities
  • Decentralization of Diagnostic Workflows Supports Integration in Ambulatory and Rural Healthcare Settings
  • Development of Multiplex Immunoassays and Serological Panels Expands Role in Surveillance Programs
  • OEM Investment in Automation and Workflow Integration Improves Lab Efficiency and Throughput
  • Focus on Panel Flexibility and Modular Testing Drives Customization for Niche Clinical Needs
  • Emergence of Home-Based and Self-Collection Multiplex Kits Expands Consumer Access and Monitoring
  • Increased Pandemic Preparedness Investments Sustain Demand for Scalable, Rapid Multi-Pathogen Detection
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Multiplexed Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Multiplexed Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Multiplexed Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Instruments & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Instruments & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Instruments & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Infectious Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Autoimmune Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Cardiac Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Cardiac Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Cardiac Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Allergies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Allergies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Allergies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 65: China Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Multiplexed Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Multiplexed Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 86: France Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 113: UK Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Multiplexed Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 170: India Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Multiplexed Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Multiplexed Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Multiplexed Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Multiplexed Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Multiplexed Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Multiplexed Diagnostics by Product Type - Instruments & Accessories and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Multiplexed Diagnostics by Product Type - Percentage Breakdown of Value Sales for Instruments & Accessories and Kits & Reagents for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Multiplexed Diagnostics by End-user - Diagnostic Centers, Other End-Users and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Multiplexed Diagnostics by End-user - Percentage Breakdown of Value Sales for Diagnostic Centers, Other End-Users and Hospitals for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Multiplexed Diagnostics by Application - Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Multiplexed Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION